Tiny Stock Taking on Big Pharma
Big Pharma doesn't want to CURE depression. The longer we stay depressed, the more money they make. But one new company is changing all that.
And it's not too late to capitalize today

AEMC Insider Trading (Aberdeen Emerging Markets Investment)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): £127,500
Insider Selling (Last 12 Months): GBX 0

Aberdeen Emerging Markets Investment Insider Trading History Chart

This chart shows the insider buying and selling history at Aberdeen Emerging Markets Investment by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Aberdeen Emerging Markets Investment Share Price & Price History

Current Price: GBX 720
Price Change: Price Decrease of -3 (-0.41%)
As of 06/24/2021 05:24 PM ET

This chart shows the closing price history over time for AEMC up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Seattle Cannabis Company Capitalizes on Surging Demand
The increase in the number of states that permit recreational and medical use of cannabis means that growers, processors and manufacturers of cannabis products often can’t keep up with growing demand. One Seattle weed manufacturer is poised to sell products across state lines, easing shortages. This could drive the company’s shares sky-high.
Get all the details on this potential blockbuster!

Aberdeen Emerging Markets Investment Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/17/2020John HawkinsInsiderBuy10,000GBX 700£70,000
10/6/2020John HawkinsInsiderBuy10,000GBX 575£57,500
2/4/2019Mark Hadsley ChaplinInsiderBuy5,000GBX 550£27,500
2/1/2019William Nicholas CollinsInsiderBuy3,000GBX 550£16,500
See Full Table
Insider Trading at Aberdeen Emerging Markets Investment?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Aberdeen Emerging Markets Investment and related companies.

SEC Filings (Institutional Ownership Changes) for Aberdeen Emerging Markets Investment (LON:AEMC)

Aberdeen Emerging Markets Investment Company Limited is a close-ended equity fund of funds launched and managed by Aberdeen Emerging Capital Limited. The fund invests both directly and through other funds in public equity markets of emerging market countries across the globe, with a focus on Asia, Eastern Europe, the Middle East, Africa, and Latin America. It seeks to invest in stocks of companies operating across diversified sectors. The fund employs quantitative, qualitative, and fundamental analysis with both bottom-up and top-down approaches to create its portfolio. It benchmarks the performance of its portfolio against the MSCI Emerging Markets Net Total Return Index. The fund was formerly known as Advance Developing Markets Fund Limited. Aberdeen Emerging Markets Investment Company Limited was formed on June 21, 1998 and is domiciled in Guernsey, Channel Islands.
Read More on Aberdeen Emerging Markets Investment

Today's Range

Now: GBX 720
Low: 720
High: 736

50 Day Range

MA: GBX 710.92
Low: 693
High: 724.80

52 Week Range

Now: GBX 720
Low: 525
High: 775

Volume

3,960 shs

Average Volume

21,277 shs

Market Capitalization

£330.95 million

P/E Ratio

12.68

Dividend Yield

3.16%

Beta

N/A

Who are the company insiders with the largest holdings of Aberdeen Emerging Markets Investment?

Aberdeen Emerging Markets Investment's top insider investors include:
  1. John Hawkins (Insider)
Seattle Cannabis Company Capitalizes on Surging Demand
The increase in the number of states that permit recreational and medical use of cannabis means that growers, processors and manufacturers of cannabis products often can’t keep up with growing demand. One Seattle weed manufacturer is poised to sell products across state lines, easing shortages. This could drive the company’s shares sky-high.
Get all the details on this potential blockbuster!